1. Home
  2. UTZ vs ARVN Comparison

UTZ vs ARVN Comparison

Compare UTZ & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Utz Brands Inc

UTZ

Utz Brands Inc

N/A

Current Price

$8.25

Market Cap

912.7M

ML Signal

N/A

Logo Arvinas Inc.

ARVN

Arvinas Inc.

N/A

Current Price

$13.40

Market Cap

781.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UTZ
ARVN
Founded
2018
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
912.7M
781.0M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
UTZ
ARVN
Price
$8.25
$13.40
Analyst Decision
Buy
Buy
Analyst Count
6
21
Target Price
$13.00
$15.71
AVG Volume (30 Days)
1.8M
749.6K
Earning Date
05-11-2026
05-27-2026
Dividend Yield
3.00%
N/A
EPS Growth
N/A
58.84
EPS
0.01
N/A
Revenue
$1,438,800,000.00
$262,600,000.00
Revenue This Year
$4.95
N/A
Revenue Next Year
$1.59
N/A
P/E Ratio
$857.50
N/A
Revenue Growth
2.09
N/A
52 Week Low
$8.37
$5.90
52 Week High
$14.67
$14.22

Technical Indicators

Market Signals
Indicator
UTZ
ARVN
Relative Strength Index (RSI) 29.25 55.83
Support Level N/A $11.07
Resistance Level $10.74 $13.97
Average True Range (ATR) 0.30 0.76
MACD -0.10 0.09
Stochastic Oscillator 7.64 80.54

Price Performance

Historical Comparison
UTZ
ARVN

About UTZ Utz Brands Inc

Utz Brands Inc is a manufacturer of branded salty snacks. It produces a broad offering of salty snacks, including potato chips, tortilla chips, pretzels, cheese snacks, pork skins, pub/party mixes, and other snacks. Its iconic portfolio of authentic, craft, and better-for-you (BFY) brands, which includes Utz, Zapp's, On The Border, Golden Flake, and Boulder Canyon, among others, enjoys household penetration in the United States, where its products can be found in approximately half of U.S. household. The company operates in eight manufacturing facilities with a broad range of capabilities, and its products are distributed nationally to grocery, mass, club, convenience, drug, e-commerce and other retailers through direct shipments, distributors, and approximately 2,500 DSD routes.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: